CervoMed Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
CervoMed Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue0.007.140.000.000.000.000.00
Cost of Revenue0.008.441.340.000.000.000.00
Gross Profit0.00-1.29-1.340.000.000.000.00
Operating Expenses
Research & Development18.808.441.348.509.436.625.75
Selling, General & Administrative9.176.522.147.456.444.836.17
Operating Expenses18.236.522.1416.0415.9711.5512.03
Operating Income-18.23-7.81-3.48-16.04-15.97-11.55-12.03
Other Income/Expense
Interest Income1.940.220.060.140.000.000.00
Interest Expense0.000.000.000.000.000.000.00
Other Income/Expense1.945.42-2.39-8.640.000.00-6.93
Income
Income Before Tax-16.29-2.17-5.80-24.54-15.86-11.47-18.81
Income Tax Expense0.000.000.00-0.44-1.680.33-0.44
Net Income-16.29-2.17-5.80-24.10-14.19-11.80-18.37
Net Income - Continuous Operations-16.29-2.17-5.80-24.100.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-18.23-7.81-5.80-15.94-15.87-11.37-11.92
EBIT-18.23-7.81-3.48-16.04-15.97-11.47-12.03
Depreciation & Amortization0.000.000.000.090.100.100.11
Earnings Per Share
Basic EPS-2.00-1.00-11.00-19.00--3.00-8.00
Diluted EPS-2.00-1.00-11.00-19.00-1.00-3.00-8.00
Basic Shares Outstanding8.072.660.521.3035.864.473.24
Diluted Shares Outstanding8.072.660.521.3023.900.003.24